Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Interim Statements of Loss and Comprehensive Loss (Unaudited)

v3.25.1
Condensed Consolidated Interim Statements of Loss and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenue $ 0 $ 0
Expenses:    
Research and development 2,364 6,445
General and administrative 3,097 3,315
Operating expenses 5,461 9,760
Other income/(expense):    
Interest (expense) income (84) 121
Foreign exchange gain (loss) 2 (1)
Total other (loss) income (82) 120
Net loss (5,543) (9,640)
Other comprehensive loss:    
Unrealized loss on available-for-sale securities 0 (1)
Total comprehensive loss $ (5,543) $ (9,641)
Basic loss per common share $ (2.61) $ (22.02)
Diluted loss per common share $ (2.61) $ (22.02)
Weighted average number of common shares outstanding used in the calculation of basic loss per share (in shares) 2,126,287 437,750
Weighted average number of common shares outstanding used in the calculation of diluted loss per share (in shares) 2,126,287 437,750